Elisigen
A New Standard for Gene Therapy, AAV-based Gene Therapy R&D
Elisigen has 1 recorded funding round.
- Website
- elisigen.com
- Rounds
- 1
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Elisigen is a clinical-stage biotechnology company developing AAV-based gene therapies targeting root causes of vision loss, chronic pain and other diseases.
Summary
Elisigen is a Biotech company. Investors include NH Investment & Securities and DAYLI Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elisigen"><img src="https://indexed.vc/api/badge/company/elisigen" alt="Elisigen on Indexed.vc" width="260" height="76" /></a>